a unique new oral contraceptive called Yasmin

Health Canada has approved a unique new oral contraceptive called Yasmin.

It contains 30 mcg of ethinyl estradiol...plus a different progestin called drospirenone.

Drospirenone is a spironolactone analogue that has anti-androgenic AND antimineralocorticoid activity.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote